Mechanisms by which M. tuberculosis 13KDa lectin modulates human immune responses
结核分枝杆菌 13KDa 凝集素调节人体免疫反应的机制
基本信息
- 批准号:8311544
- 负责人:
- 金额:$ 5.31万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-09-01 至 2013-08-31
- 项目状态:已结题
- 来源:
- 关键词:AgonistAntibiotic TherapyAntigen-Presenting CellsAntitubercular AgentsBacteriaBindingBiochemicalBioinformaticsBiological MarkersBlocking AntibodiesBrazilC Type Lectin ReceptorsC-Type LectinsCD209 geneCD80 geneCell CommunicationCell Culture TechniquesCell LineCell physiologyCellsCitiesCoculture TechniquesCommunicable DiseasesConfocal MicroscopyCytokine GeneCytometryDataData AnalysesDatabasesDendritic CellsDevelopmentDiagnosticDiseaseEnzyme-Linked Immunosorbent AssayErythrocytesExposure toFamilyFlow CytometryGene ExpressionGenesGenus MycobacteriumGoalsGreen Fluorescent ProteinsHealthHost resistanceHumanImmune responseImmune systemImmunityImmunoglobulin GImmunologic ReceptorsImmunotherapyIn VitroInfectionInflammation MediatorsInflammatoryInterferon Type IIInterleukin-10Interleukin-12Interleukin-17Interleukin-6KnowledgeLectinLung diseasesMHC Class II GenesMacrophage-1 AntigenMeasuresMembraneModelingMonoclonal AntibodiesMusMycobacterium smegmatisMycobacterium tuberculosisOutcomeOutcome StudyPathogenesisPathway interactionsPatient MonitoringPatientsPatternPeripheral Blood Mononuclear CellPhagocytosisPlayPreparationProcessProductionProtein Binding DomainProteinsPublishingReagentRecombinantsResearchRicinRoleScreening procedureSerumSurfaceSystemT-Cell ProliferationT-LymphocyteTLR2 geneTLR3 geneTLR4 geneTLR7 geneTNF geneTNFRSF5 geneTestingTimeToll-like receptorsTuberculosisVirulenceWorkbasechemotherapycohortcytokinedectin 1glucan phosphateimmunoprophylaxisimprovedin vivointerestinterleukin-23laminaranmacrophagemonocytemycobacterialneutralizing antibodynovelpathogenprotein protein interactionreceptorreceptor expressionresearch studyresponsestemsugartooltuberculosis treatmentuptake
项目摘要
Mechanisms by which M. tuberculosis 13 kDa lectin modulates human
immune responses
Project Summary
Study of novel proteins from Mycobacterium tuberculosis may be a critical step for
improving diagnostic tools, therapies and immunoprophylaxis against tuberculosis (TB),
one of the most prevalent infectious diseases wordwide. We have identified a 13 KDa
ricin-like lectin from M. tuberculosis that was found to agglutinate red blood cells and
induce cytokine expression by macrophages. Moreover, serum from active tuberculosis
patients contained high levels of IgG against this lectin. In the present proposal, we aim
to characterize the role of 13 KDa Mtb lectin on human immune responses. The specific
aims of the study are to 1) characterize the innate immune response profile elicited
by the 13 KDa Mtb lectin; 2) determine innate receptor(s) expressed on human
APC involved in the recognition of 13 KDa Mtb lectin; 3) investigate the role of 13
KDa Mtb lectin in the infection/phagocytosis process of M. tuberculosis by human
APC and 4) examine specific humoral and cellular immune responses against 13
KDa Mtb lectin in TB patients before and after antibiotic treatment. Our long-term
goal is to determine whether 13 KDa Mtb ricin-like lectin plays a role in regulating human
immune responses to TB focusing on it possible activity in controlling APC function.
These studies could be important in revealing a new target for immunotherapy of
tuberculosis.
结核分枝杆菌13 kDa凝集素调节人类的机制
免疫反应
项目摘要
研究结核分枝杆菌的新蛋白质可能是关键的步骤
改善针对结核病(TB)的诊断工具,疗法和免疫预防,
最普遍的传染病之一是Wordwide。我们已经确定了13 kDa
结核分枝杆菌的丽菌素样凝集素被发现凝集红细胞和
通过巨噬细胞诱导细胞因子表达。此外,活性结核病的血清
患者对此凝集素的IgG含量很高。在本提案中,我们的目标
为了表征13 kDa MTB凝集素对人免疫反应的作用。具体
该研究的目的是1)特征是引起先天免疫反应曲线
由13 kDa mtb凝集素; 2)确定在人类上表达的先天受体
APC参与了13 kDa MTB凝集素的识别; 3)研究13的作用
人类结核分枝杆菌的感染/吞噬作用过程中的KDA MTB凝集素
APC和4)检查针对13的特定体液和细胞免疫反应
抗生素治疗前后结核病患者的KDA MTB凝集素。我们的长期
目标是确定13 kDa mtb ricin样凝集素是否在调节人中起作用
对结核病的免疫反应集中在控制APC功能时可能的活动。
这些研究对于揭示新的免疫疗法的新靶标可能很重要
结核。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Andre Bafica其他文献
Andre Bafica的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Andre Bafica', 18)}}的其他基金
Mechanisms by which M. tuberculosis 13KDa lectin modulates human immune responses
结核分枝杆菌 13KDa 凝集素调节人体免疫反应的机制
- 批准号:
7688816 - 财政年份:2009
- 资助金额:
$ 5.31万 - 项目类别:
Mechanisms by which M. tuberculosis 13KDa lectin modulates human immune responses
结核分枝杆菌 13KDa 凝集素调节人体免疫反应的机制
- 批准号:
8712591 - 财政年份:2009
- 资助金额:
$ 5.31万 - 项目类别:
Mechanisms by which M. tuberculosis 13KDa lectin modulates human immune responses
结核分枝杆菌 13KDa 凝集素调节人体免疫反应的机制
- 批准号:
7922655 - 财政年份:2009
- 资助金额:
$ 5.31万 - 项目类别:
Mechanisms by which M. tuberculosis 13KDa lectin modulates human immune responses
结核分枝杆菌 13KDa 凝集素调节人体免疫反应的机制
- 批准号:
8508839 - 财政年份:2009
- 资助金额:
$ 5.31万 - 项目类别:
相似海外基金
Regulation of Liver DC Function and Transplant Tolerance
肝脏 DC 功能和移植耐受的调节
- 批准号:
9927591 - 财政年份:2017
- 资助金额:
$ 5.31万 - 项目类别:
Regulation of Liver DC Function and Transplant Tolerance
肝脏 DC 功能和移植耐受的调节
- 批准号:
9372923 - 财政年份:2017
- 资助金额:
$ 5.31万 - 项目类别:
Regulation of Liver DC Function and Transplant Tolerance
肝脏 DC 功能和移植耐受的调节
- 批准号:
10172828 - 财政年份:2017
- 资助金额:
$ 5.31万 - 项目类别:
Mechanisms by which M. tuberculosis 13KDa lectin modulates human immune responses
结核分枝杆菌 13KDa 凝集素调节人体免疫反应的机制
- 批准号:
7688816 - 财政年份:2009
- 资助金额:
$ 5.31万 - 项目类别:
Mechanisms by which M. tuberculosis 13KDa lectin modulates human immune responses
结核分枝杆菌 13KDa 凝集素调节人体免疫反应的机制
- 批准号:
8712591 - 财政年份:2009
- 资助金额:
$ 5.31万 - 项目类别: